Thioredoxin concentration in RA patients might be involved in the aggravation of rheumatoid inflammation by augmenting the NF-kappa B activation pathway, and Thioredoxin 1 is associated with the proliferation and apoptosis of RA fibroblast-like synoviocytes (Lu et al., 2018). This evidence concerns the gene TXN and rheumatoid arthritis.